Cargando…
One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the autoimmune destruction of pancreatic β-cells. This paper describes the case of a 19-year-old male patient who presented with glutamic acid decarboxylase (GAD) antibody positive and diabetic ketoacidosis, which mandated intensi...
Autores principales: | Lima-Martínez, Marcos M, Guerra-Alcalá, Ernesto, Contreras, Miguel, Nastasi, José, Noble, Janelle A, Polychronakos, Constantin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190822/ https://www.ncbi.nlm.nih.gov/pubmed/25332771 http://dx.doi.org/10.1530/EDM-14-0072 |
Ejemplares similares
-
Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3
por: Pinheiro, Marcelo Maia, et al.
Publicado: (2016) -
Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
por: Alvarez-Escola, Cristina, et al.
Publicado: (2016) -
A case with relapsed transient neonatal diabetes mellitus treated with sulfonylurea, ending chronic insulin requirement
por: Ando, Akihiko, et al.
Publicado: (2018) -
Simultaneous onset of type 1 diabetes mellitus and silent thyroiditis under durvalumab treatment
por: León Mengíbar, Jose, et al.
Publicado: (2019) -
New onset autoimmune diabetes mellitus and hypothyroidism secondary to pembrolizumab in a patient with metastatic lung cancer
por: Cunha, Clara, et al.
Publicado: (2022)